ACHE and Alzheimer disease: Galasko and colleagues conducted a three-arm double-blind, placebo-controlled clinical trial on patients with mild to moderate Alzheimer’s disease treated with either acetylcholinesterase or memantine; the treatment included (1) high-dose ALA (900 mg/day) combined with vitamins C and E, (2) coenzyme Q, and (3) placebo.